| Ruth Elaine Baker, MD | |
|
294 Summar Dr, Jackson, TN 38301-3915 | |
| (731) 423-1932 | |
| (731) 410-0367 |
| Full Name | Ruth Elaine Baker |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 28 Years |
| Location | 294 Summar Dr, Jackson, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104923598 | NPI | - | NPPES |
| 000863068E | Medicaid | GA | |
| 048478 | Other | GA | GA LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 048478 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wt University Medical Associates Inc | 3779824719 | 17 |
News Archive
The rising prevalence of dental erosion and dentin hypersensitivity has led to the emergence of more and more toothpastes on the market that claim to treat these problems. While no such toothpaste existed 20 years ago, today, many brands with different attributes are being offered.
The Premier healthcare alliance today announced that new agreements for talent management solutions have been awarded to Astron Solutions of New York, a small business enterprise; and TEDS Inc. of Atkins, Va., a small business enterprise.
Results from two subgroup analyses of the Phase IV independent TWILIGHT trial funded by AstraZeneca showed Brilinta (ticagrelor) monotherapy reduced the risk of clinically relevant bleeding over 12 months compared to aspirin plus Brilinta in high-risk coronary patients.
Vital Access Corporation today announced the launch of the SAVE-2 post-market clinical follow-up study. The SAVE-2 study follows the U.S. SAVE study, an IDE pivotal trial that clearly demonstrated the benefits of the VWING™ Vascular Needle Guide in restoring vascular access to hemodialysis patients with uncannulatable and deep arteriovenous fistulae.
› Verified 8 days ago
| Entity Name | University Of Tennessee |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780686436 PECOS PAC ID: 3072421213 Enrollment ID: O20031119000671 |
News Archive
The rising prevalence of dental erosion and dentin hypersensitivity has led to the emergence of more and more toothpastes on the market that claim to treat these problems. While no such toothpaste existed 20 years ago, today, many brands with different attributes are being offered.
The Premier healthcare alliance today announced that new agreements for talent management solutions have been awarded to Astron Solutions of New York, a small business enterprise; and TEDS Inc. of Atkins, Va., a small business enterprise.
Results from two subgroup analyses of the Phase IV independent TWILIGHT trial funded by AstraZeneca showed Brilinta (ticagrelor) monotherapy reduced the risk of clinically relevant bleeding over 12 months compared to aspirin plus Brilinta in high-risk coronary patients.
Vital Access Corporation today announced the launch of the SAVE-2 post-market clinical follow-up study. The SAVE-2 study follows the U.S. SAVE study, an IDE pivotal trial that clearly demonstrated the benefits of the VWING™ Vascular Needle Guide in restoring vascular access to hemodialysis patients with uncannulatable and deep arteriovenous fistulae.
› Verified 8 days ago
| Entity Name | Obhg Tennessee, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285924977 PECOS PAC ID: 1850566514 Enrollment ID: O20111207000456 |
News Archive
The rising prevalence of dental erosion and dentin hypersensitivity has led to the emergence of more and more toothpastes on the market that claim to treat these problems. While no such toothpaste existed 20 years ago, today, many brands with different attributes are being offered.
The Premier healthcare alliance today announced that new agreements for talent management solutions have been awarded to Astron Solutions of New York, a small business enterprise; and TEDS Inc. of Atkins, Va., a small business enterprise.
Results from two subgroup analyses of the Phase IV independent TWILIGHT trial funded by AstraZeneca showed Brilinta (ticagrelor) monotherapy reduced the risk of clinically relevant bleeding over 12 months compared to aspirin plus Brilinta in high-risk coronary patients.
Vital Access Corporation today announced the launch of the SAVE-2 post-market clinical follow-up study. The SAVE-2 study follows the U.S. SAVE study, an IDE pivotal trial that clearly demonstrated the benefits of the VWING™ Vascular Needle Guide in restoring vascular access to hemodialysis patients with uncannulatable and deep arteriovenous fistulae.
› Verified 8 days ago
| Entity Name | Wt University Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023572344 PECOS PAC ID: 3779824719 Enrollment ID: O20190401001719 |
News Archive
The rising prevalence of dental erosion and dentin hypersensitivity has led to the emergence of more and more toothpastes on the market that claim to treat these problems. While no such toothpaste existed 20 years ago, today, many brands with different attributes are being offered.
The Premier healthcare alliance today announced that new agreements for talent management solutions have been awarded to Astron Solutions of New York, a small business enterprise; and TEDS Inc. of Atkins, Va., a small business enterprise.
Results from two subgroup analyses of the Phase IV independent TWILIGHT trial funded by AstraZeneca showed Brilinta (ticagrelor) monotherapy reduced the risk of clinically relevant bleeding over 12 months compared to aspirin plus Brilinta in high-risk coronary patients.
Vital Access Corporation today announced the launch of the SAVE-2 post-market clinical follow-up study. The SAVE-2 study follows the U.S. SAVE study, an IDE pivotal trial that clearly demonstrated the benefits of the VWING™ Vascular Needle Guide in restoring vascular access to hemodialysis patients with uncannulatable and deep arteriovenous fistulae.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ruth Elaine Baker, MD 294 Summar Dr, Jackson, TN 38301-3915 Ph: (731) 423-1932 | Ruth Elaine Baker, MD 294 Summar Dr, Jackson, TN 38301-3915 Ph: (731) 423-1932 |
News Archive
The rising prevalence of dental erosion and dentin hypersensitivity has led to the emergence of more and more toothpastes on the market that claim to treat these problems. While no such toothpaste existed 20 years ago, today, many brands with different attributes are being offered.
The Premier healthcare alliance today announced that new agreements for talent management solutions have been awarded to Astron Solutions of New York, a small business enterprise; and TEDS Inc. of Atkins, Va., a small business enterprise.
Results from two subgroup analyses of the Phase IV independent TWILIGHT trial funded by AstraZeneca showed Brilinta (ticagrelor) monotherapy reduced the risk of clinically relevant bleeding over 12 months compared to aspirin plus Brilinta in high-risk coronary patients.
Vital Access Corporation today announced the launch of the SAVE-2 post-market clinical follow-up study. The SAVE-2 study follows the U.S. SAVE study, an IDE pivotal trial that clearly demonstrated the benefits of the VWING™ Vascular Needle Guide in restoring vascular access to hemodialysis patients with uncannulatable and deep arteriovenous fistulae.
› Verified 8 days ago
Dr. Molly Rheney, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 244 Coatsland Dr, Jackson, TN 38301 Phone: 731-422-4642 Fax: 731-422-2277 | |
Dr. Andrea Marshall Harper, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 244 Coatsland Dr, Jackson, TN 38301 Phone: 731-422-4642 Fax: 731-422-2277 | |
John J Ball, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 379 Hospital Blvd, Jackson, TN 38305 Phone: 731-660-3344 Fax: 731-660-3347 | |
Mrs. Leila Keel Nichols, CNM Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2863 Highway 45 Byp, Jackson, TN 38305 Phone: 731-660-8300 Fax: 731-660-8301 | |
Ryan Allen Roy, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 244 Coatsland Dr, Jackson, TN 38301 Phone: 731-422-4642 Fax: 731-422-2277 | |
Elliott C Roberts Jr., MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 657 Skyline Dr, Jackson, TN 38301 Phone: 731-541-8425 Fax: 731-541-8420 |